We will be performing routine ERA maintenance starting 3PM Tuesday Feb 19 until 3PM Wednesday Feb 20. ERA searches and downloads will perform as usual, but the "Deposit" and "Edit" function will be suspended during the maintenance period. When the work is complete, we'll remove this notice. Thanks for your understanding!
- 30 views
- 10 downloads
Newborn blood spot screening for galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and severe combined immunodeficiency
-
- Author(s) / Creator(s)
-
This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and severe combined immunodeficiency), contextualized to the Alberta setting.
-
- Date created
- 2016-03-23
-
- Subjects / Keywords
-
- Type of Item
- Report